MICHELLE HAGEN: Open Payments
NPI 1982183208 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 65 payments from 12 companies in 2025. Trend: 2023 $1,084 · 2024 $1,078 · 2025 $2,653
Food & beverage: $1,528Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| MML US, Inc. | 12 | $1,358 |
| BIOTRONIK NRO, Inc. | 15 | $378 |
| ABBVIE INC. | 8 | $213 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $159 |
| Boston Scientific Corporation | 4 | $144 |
| Collegium Pharmaceutical, Inc. | 6 | $115 |
| Abbott Laboratories | 4 | $83 |
| Globus Medical, Inc. | 3 | $63 |
| Medtronic, Inc. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
Products named: ReActiv8, Prospera, JOURNAVX, UBRELVY, Intracept, Belbuca, PROCLAIM, QULIPTA.
Industry payments across TX — which companies pay providers there.
